REPORT FROM THE AAN, APRIL 10-17, 2010 – Results of a randomized trial of adjunctive prolonged-release ropinirole indicate that the dopamine agonist may provide better 24-hour symptom control in advanced PD patients treated with L-dopa (Stocchi et al. AAN, S33.003).